Spyre Therapeutics Inc

NEW
STU:3920 (USA)  
€ 78.5 -2 (-2.48%) Sep 18
At Loss
P/B:
8.46
Market Cap:
€ 6.93B ($ 7.97B)
Enterprise V:
€ 6.06B ($ 6.97B)
Volume:
0
Avg Vol (2M):
40.00
Trade In:

Spyre Therapeutics Inc Valuation Measures